Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to ...

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by ...

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and ...

Sanofi’s Sarclisa (isatuximab) has been approved by the European Commission (EC) to treat newly diagnosed multiple myeloma ...

Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been recommended by the European Medicines Agency’s human medicines ...

Listening to patients and HCPs helps strike the right notes to deliver harmony across engagement and activation ...

Communiqué 2025: celebrating excellence in healthcare comms! This year marks the 27th year of the Comm uniqué Awards, celebrating excellence in healthcare communications and showcasing the work that ...

Merck & Co – known as MSD outside of the US and Canada – has unveiled a new cost-cutting plan aimed at saving $3bn every year ...

Havas Lynx has announced the appointment of Talin Apkarian as Havas Lynx Hudson managing director.

Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...

Walawalkar most recently served as chief strategy officer, international brands at MullenLowe Global, part of IPG ...